NCT03450005
ECMM Candida Registry - CandiReg No drug interventions Not Available Not Available recruiting NCT03090334
A B-D-Glucan Driven Antifungal Stewardship Approach for Invasive Candidiasis No drug interventions other Not Available terminated NCT05848492
Efficacy of Prophylactic Fluconazole Therapy in Preterm and Very Low Birth Weight Neonates in Preventing Invasive Fungal Infection. prevention 3 completed NCT03468803
Influence of Open and Laparoscopic Abdominal Surgery Involving the Intestinal Tract on Serum 1,3-ß-D-Glucan (BDG) Values No drug interventions diagnostic Not Available completed NCT03667690
Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis treatment 3 completed NCT04148287
An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris treatment 2 completed NCT03717623
Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants treatment 4 recruiting NCT05421858
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis. treatment 3 not_yet_recruiting NCT05264571
Early Identification of Candida in Intra-abdominal Candidiasis No drug interventions Not Available Not Available completed NCT02244606
Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis treatment 2 completed NCT00413218
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections treatment 3 completed NCT03363841
Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES) treatment 3 completed NCT01165320
A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074) treatment 2 completed NCT05178862
A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole treatment 3 suspended NCT03997929
Peritoneal 1.3-ß-D-glucan for the Diagnosis of Intra-abdominal Candidiasis in Critically Ill Patients (pBDG2) No drug interventions Not Available Not Available completed NCT01945281
Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064) treatment 2 terminated NCT05763251
Comparison of Uncomplicated Candidemia Therapy Duration in Children No drug interventions treatment Not Available recruiting NCT00786903
Candida Spp. in the Lower Respiratory Tract: Harmless Residents or Pathogen? No drug interventions Not Available Not Available completed NCT02164890
Pharmacokinetics of Micafungin in Patients of Intensive Care Units No drug interventions other 4 completed NCT05707832
A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus treatment 3 not_yet_recruiting NCT00520234
Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU) prevention 4 completed NCT00607763
Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug Not Available 1 completed NCT00670657
CRITIC - Treatment of Candidemia and Invasive Candidiasis treatment 4 completed NCT02801682
NOBICS - NOvel BIomarker In Invasive CandidiasiS/Candida Sepsis No drug interventions Not Available Not Available completed NCT01773876
Empirical Antifungal Treatment in ICUS treatment 3 completed NCT00548262
This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis treatment 4 completed NCT02734862
CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension treatment 2 completed NCT03059992
Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment treatment 3 completed NCT01047267
Pharmacokinetics of Anidulafungin on Intensive Care Unit (ICU) No drug interventions Not Available Not Available completed NCT02841501
Genetic Susceptibility Factors for Candidemia. No drug interventions Not Available Not Available completed NCT01666769
Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation treatment 1 completed NCT02220790
BIOPIC: Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric Candidemia No drug interventions Not Available Not Available completed NCT01490684
Invasive Candidiasis in Saudi ICUs No drug interventions Not Available Not Available completed NCT06456151
Invasive Candidiasis in Critical Care No drug interventions Not Available Not Available recruiting NCT02491151
Variability of Fluconazole Concentration in Critically Ill Patients No drug interventions Not Available Not Available completed NCT01045798
Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067) treatment 2 terminated NCT01716988
Pharmacokinetics of Micafungin in Critically Ill Patients No drug interventions Not Available Not Available completed NCT00189709
Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia treatment 3 completed NCT00250432
A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED) treatment 3 completed NCT04368559
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation prevention 3 recruiting NCT00672841
β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients treatment Not Available completed NCT01438216
Anidulafungin Pharmacokinetics in Intensive Care Unit Patients No drug interventions Not Available Not Available unknown_status NCT03906916
Comparison of Two Diagnostic Tests in Patients With Suspected Invasive Candidiasis in Internal Medicine Wards and Who Are Currently Timely Treated With Micafungin diagnostic 4 terminated NCT00608335
Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug other 1 completed NCT05496725
Evaluate Bioequivalence of Micafungin (50mg/Vial) other 4 completed NCT03538912
Early Discontinuation of Empirical Antifungal Therapy and Biomarkers No drug interventions treatment Not Available recruiting NCT04225195
Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive Aspergillosis treatment 2 unknown_status NCT01213823
Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins No drug interventions Not Available Not Available terminated NCT00689338
Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study treatment 3 completed